Narang Medical Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 16-11-2024
- Paid Up Capital ₹ 2.50 M
as on 16-11-2024
- Company Age 20 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.57 Cr
as on 16-11-2024
- Revenue 12.34%
(FY 2023)
- Profit 27.47%
(FY 2023)
- Ebitda 65.15%
(FY 2023)
- Net Worth 19.79%
(FY 2023)
- Total Assets 20.06%
(FY 2023)
About Narang Medical
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹4.57 Cr.
Parveen Narang, Vivek Narang, Gurdeep Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U33119DL2004PLC124816
- Company No.
124816
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Feb 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Narang Medical Limited offer?
Narang Medical Limited offers a wide range of products and services, including Surgical & ICU Equipments, Pulse Oximeter, Glucometer & POCT Devices, Surgical & Medical Consumables, Surgical Disposables, Hospital and Medical Furniture, Medical Trolley, Hospital Tables, Rubber & Rubber Products, Molded Rubber Products, Physiotherapy & Rehab Aids.
Who are the key members and board of directors at Narang Medical?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parveen Narang  | Whole-Time Director | 24-Feb-2006 | Current |
| Vivek Narang | Whole-Time Director | 24-Feb-2006 | Current |
| Gurdeep Singh | Director | 01-Apr-2008 | Current |
| Sumit Chauhan | Director | 01-Dec-2014 | Current |
Financial Performance of Narang Medical.
Narang Medical Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.34% increase. The company also saw a substantial improvement in profitability, with a 27.47% increase in profit. The company's net worth Soared by an impressive increase of 19.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Narang Medical?
In 2023, Narang Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Jul 2022 | ₹0.73 M | Open |
Axis Bank Ltd. Creation Date: 13 Sep 2013 | ₹4.50 Cr | Open |
How Many Employees Work at Narang Medical?
Narang Medical has a workforce of 94 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Narang Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narang Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
